Assembling an orchestra: Fanconi anemia pathway of DNA repair

Frontiers in Bioscience

Volumn 15, Issue 3, 2010, Pages 1131-1149

  Yuan, Fenghua ^a   Song, Limin ^a   Qian, Liangyue ^a   Hu, Jennifer J ^a   Zhang, Yanbin ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Dna repair; Fanconi anemia; Homologous recombination; Icl incision; Interstrand crosslink; Replication; Review; Translesion synthesis

Indexed keywords

VERTEBRATA;

FANCONI ANEMIA PROTEIN;

ANIMAL; BIOLOGICAL MODEL; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; MODELS, GENETIC; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 77956621425     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3666     Document Type: Article

References (223)

1. B. P. Alter: Cancer in Fanconi anemia, 1927-2001. Cancer, 97(2), 425-40 (2003). (Pubitemid 36133810)
2. M. D. Tischkowitz and S. V. Hodgson: Fanconi anaemia. J Med Genet, 40(1), 1-10 (2003). (Pubitemid 36115118)
3. C. G. Mathew: Fanconi anaemia genes and susceptibility to cancer. Oncogene, 25(43), 5875-84 (2006). (Pubitemid 44453443)
4. M. Levitus, H. Joenje and J. P. de Winter: The Fanconi anemia pathway of genomic maintenance. Cell Oncol, 28(1-2), 3-29 (2006). (Pubitemid 43673124)
5. W. Wang: Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet, 8(10), 735-48 (2007). (Pubitemid 47429206)
6. L. H. Thompson, J. M. Hinz, N. A. Yamada and N. J. Jones: How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ Mol Mutagen, 45(2-3), 128-42 (2005).
7. L. J. Niedernhofer, A. S. Lalai and J. H. Hoeijmakers: Fanconi anemia (cross)linked to DNA repair. Cell, 123(7), 1191-8 (2005). (Pubitemid 41821778)
8. A. D. Auerbach: Fanconi anemia and its diagnosis. Mutat Res, 668(1-2), 4-10 (2009).
9. A. D. D'Andrea and M. Grompe: The Fanconi anaemia/BRCA pathway. Nat Rev Cancer, 3(1), 23-34 (2003). (Pubitemid 37328884)
10. K. J. Patel and H. Joenje: Fanconi anemia and DNA replication repair. DNA Repair (Amst), 6(7), 885-90 (2007). (Pubitemid 46880469)
11. H. Joenje and K. J. Patel: The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet, 2(6), 446- 57 (2001). (Pubitemid 33673411)
12. G. L. Moldovan and A. D. D'Andrea: How the Fanconi Anemia Pathway Guards the Genome. Annu Rev Genet, 43, 223-49 (2009).
13. M. S. Sasaki: Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links? Nature, 257(5526), 501-3 (1975).
14. Y. M. Akkari, R. L. Bateman, C. A. Reifsteck, S. B. Olson and M. Grompe: DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol Cell Biol, 20(21), 8283-9 (2000).
15. I. U. De Silva, P. J. McHugh, P. H. Clingen and J. A. Hartley: Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol, 20(21), 7980-90 (2000).
16. M. Raschle, P. Knipsheer, M. Enoiu, T. Angelov, J. Sun, J. D. Griffith, T. E. Ellenberger, O. D. Scharer and J. C. Walter: Mechanism of replication-coupled DNA interstrand crosslink repair. Cell, 134(6), 969-80 (2008).
17. J. M. Hinz, P. B. Nham, S. S. Urbin, I. M. Jones and L. H. Thompson: Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res, 35(11), 3733-40 (2007). (Pubitemid 47244666)
18. A. Sobeck, S. Stone, V. Costanzo, B. de Graaf, T. Reuter, J. de Winter, M. Wallisch, Y. Akkari, S. Olson, W. Wang, H. Joenje, J. L. Christian, P. J. Lupardus, K. A. Cimprich, J. Gautier and M. E. Hoatlin: Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol Cell Biol, 26(2), 425-37 (2006). (Pubitemid 43089757)
19. L. H. Thompson and J. M. Hinz: Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: Mechanistic insights. Mutat Res, 668(1-2), 54-72 (2009).
20. L. C. Wang, S. Stone, M. E. Hoatlin and J. Gautier: Fanconi anemia proteins stabilize replication forks. DNA Repair (Amst), 7(12), 1973-81 (2008).
21. F. Yuan, J. El Hokayem, W. Zhou and Y. Zhang: FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. J Biol Chem, 284(36), 24443-24452 (2009).
22. K. Gari, C. Decaillet, M. Delannoy, L. Wu and A. Constantinou: Remodeling of DNA replication structures by the branch point translocase FANCM. Proc Natl Acad Sci U S A, 105(42), 16107-12 (2008).
23. K. Gari, C. Decaillet, A. Z. Stasiak, A. Stasiak and A. Constantinou: The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol Cell, 29(1), 141-8 (2008).
24. Y. Xue, Y. Li, R. Guo, C. Ling and W. Wang: FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum Mol Genet, 17(11), 1641-52 (2008). (Pubitemid 351737168)
25. H. Joenje, F. Arwert, A. W. Eriksson, H. de Koning and A. B. Oostra: Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature, 290(5802), 142-3 (1981). (Pubitemid 11149688)
26. M. R. Saadatzadeh, K. Bijangi-Vishehsaraei, P. Hong, H. Bergmann and L. S. Haneline: Oxidant hypersensitivity of Fanconi anemia type C-deficient cells is dependent on a redox-regulated apoptotic pathway. J Biol Chem, 279(16), 16805-12 (2004). (Pubitemid 38509383)
27. D. Schindler and H. Hoehn: Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet, 43(4), 429-35 (1988).
28. O. Cohen-Haguenauer, B. Peault, C. Bauche, M. T. Daniel, I. Casal, V. Levy, J. Dausset, M. Boiron, C. Auclair, E. Gluckman and M. Marty: In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients. Proc Natl Acad Sci U S A, 103(7), 2340-5 (2006). (Pubitemid 43271671)
29. M. Futaki, T. Igarashi, S. Watanabe, S. Kajigaya, A. Tatsuguchi, J. Wang and J. M. Liu: The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis, 23(1), 67-72 (2002). (Pubitemid 34213553)
30. F. A. Kruyt, T. Hoshino, J. M. Liu, P. Joseph, A. K. Jaiswal and H. Youssoufian: Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood, 92(9), 3050-6 (1998). (Pubitemid 28492309)
31. S. J. Park, S. L. Ciccone, B. D. Beck, B. Hwang, B. Freie, D. W. Clapp and S. H. Lee: Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins. J Biol Chem, 279(29), 30053-9 (2004). (Pubitemid 38937926)
32. S. Hadjur, K. Ung, L. Wadsworth, J. Dimmick, E. Rajcan-Separovic, R. W. Scott, M. Buchwald and F. R. Jirik: Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. Blood, 98(4), 1003-11 (2001).
33. G. Pagano, P. Degan, M. d'Ischia, F. J. Kelly, B. Nobili, F. V. Pallardo, H. Youssoufian and A. Zatterale: Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype. Eur J Haematol, 75(2), 93-100 (2005). (Pubitemid 41008278)
34. G. Pagano and H. Youssoufian: Fanconi anaemia proteins: major roles in cell protection against oxidative damage. Bioessays, 25(6), 589-95 (2003). (Pubitemid 36705510)
35. Q. Pang and P. R. Andreassen: Fanconi anemia proteins and endogenous stresses. Mutation Research, 668, 42-53 (2009).
36. S. I. Ahmad, F. Hanaoka and S. H. Kirk: Molecular biology of Fanconi anaemia-an old problem, a new insight. Bioessays, 24(5), 439-48 (2002). (Pubitemid 34499812)
37. R. Rani, J. Li and Q. Pang: Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice. Cancer Res, 68(23), 9693-702 (2008).
38. D. P. Sejas, R. Rani, Y. Qiu, X. Zhang, S. R. Fagerlie, H. Nakano, D. A. Williams and Q. Pang: Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice. J Immunol, 178(8), 5277-87 (2007). (Pubitemid 46595313)
39. X. Zhang, J. Li, D. P. Sejas and Q. Pang: Hypoxiareoxygenation induces premature senescence in FA bone marrow hematopoietic cells. Blood, 106(1), 75-85 (2005). (Pubitemid 40967177)
40. X. Zhang, D. P. Sejas, Y. Qiu, D. A. Williams and Q. Pang: Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence. J Cell Sci, 120(Pt 9), 1572-83 (2007). (Pubitemid 46831787)
41. J. Grillari, H. Katinger and R. Voglauer: Contributions of DNA interstrand cross-links to aging of cells and organisms. Nucleic Acids Res, 35(22), 7566-76 (2007).
42. L. J. Niedernhofer, J. S. Daniels, C. A. Rouzer, R. E. Greene and L. J. Marnett: Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem, 278(33), 31426-33 (2003). (Pubitemid 36994664)
43. M. L. Dronkert and R. Kanaar: Repair of DNA interstrand cross-links. Mutat Res, 486(4), 217-47 (2001). (Pubitemid 32763210)
44. M. P. Stone, Y. J. Cho, H. Huang, H. Y. Kim, I. D. Kozekov, A. Kozekova, H. Wang, I. G. Minko, R. S. Lloyd, T. M. Harris and C. J. Rizzo: Interstrand DNA cross-links induced by alpha, beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc Chem Res, 41(7), 793-804 (2008).
45. J. R. Lo Ten Foe, M. A. Rooimans, L. Bosnoyan-Collins, N. Alon, M. Wijker, L. Parker, J. Lightfoot, M. Carreau, D. F. Callen, A. Savoia, N. C. Cheng, C. G. van Berkel, M. H. Strunk, J. J. Gille, G. Pals, F. A. Kruyt, J. C. Pronk, F. Arwert, M. Buchwald and H. Joenje: Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet, 14(3), 320-3 (1996).
46. A. R. Meetei, M. Levitus, Y. Xue, A. L. Medhurst, M. Zwaan, C. Ling, M. A. Rooimans, P. Bier, M. Hoatlin, G. Pals, J. P. de Winter, W. Wang and H. Joenje: X-linked inheritance of Fanconi anemia complementation group B. Nat Genet, 36(11), 1219-24 (2004).
47. C. A. Strathdee, H. Gavish, W. R. Shannon and M. Buchwald: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature, 356(6372), 763-7 (1992).
48. N. G. Howlett, T. Taniguchi, S. Olson, B. Cox, Q. Waisfisz, C. De Die-Smulders, N. Persky, M. Grompe, H. Joenje, G. Pals, H. Ikeda, E. A. Fox and A. D. D'Andrea: Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297(5581), 606-9 (2002). (Pubitemid 34815345)
49. C. Timmers, T. Taniguchi, J. Hejna, C. Reifsteck, L. Lucas, D. Bruun, M. Thayer, B. Cox, S. Olson, A. D. D'Andrea, R. Moses and M. Grompe: Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell, 7(2), 241-8 (2001). (Pubitemid 32206492)
50. J. P. de Winter, F. Leveille, C. G. van Berkel, M. A. Rooimans, L. van Der Weel, J. Steltenpool, I. Demuth, N. V. Morgan, N. Alon, L. Bosnoyan-Collins, J. Lightfoot, P. A. Leegwater, Q. Waisfisz, K. Komatsu, F. Arwert, J. C. Pronk, C. G. Mathew, M. Digweed, M. Buchwald and H. Joenje: Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet, 67(5), 1306-8 (2000).
51. J. P. de Winter, M. A. Rooimans, L. van Der Weel, C. G. van Berkel, N. Alon, L. Bosnoyan-Collins, J. de Groot, Y. Zhi, Q. Waisfisz, J. C. Pronk, F. Arwert, C. G. Mathew, R. J. Scheper, M. E. Hoatlin, M. Buchwald and H. Joenje: The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet, 24(1), 15-6 (2000). (Pubitemid 30041412)
52. J. P. de Winter, Q. Waisfisz, M. A. Rooimans, C. G. van Berkel, L. Bosnoyan-Collins, N. Alon, M. Carreau, O. Bender, I. Demuth, D. Schindler, J. C. Pronk, F. Arwert, H. Hoehn, M. Digweed, M. Buchwald and H. Joenje: The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet, 20(3), 281-3 (1998). (Pubitemid 28507674)
53. A. Smogorzewska, S. Matsuoka, P. Vinciguerra, E. R. McDonald 3rd, K. E. Hurov, J. Luo, B. A. Ballif, S. P. Gygi, K. Hofmann, A. D. D'Andrea and S. J. Elledge: Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA Repair. Cell, 129, 289-301 (2007). (Pubitemid 46584733)
54. A. E. Sims, E. Spiteri, R. J. Sims 3rd, A. G. Arita, F. P. Lach, T. Landers, M. Wurm, M. Freund, K. Neveling, H. Hanenberg, A. D. Auerbach and T. T. Huang: FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol, 14(6), 564-7 (2007). (Pubitemid 46871814)
55. J. C. Dorsman, M. Levitus, D. Rockx, M. A. Rooimans, A. B. Oostra, A. Haitjema, S. T. Bakker, J. Steltenpool, D. Schuler, S. Mohan, D. Schindler, F. Arwert, G. Pals, C. G. Mathew, Q. Waisfisz, J. P. de Winter and H. Joenje: Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol, 29(3), 211-8 (2007). (Pubitemid 46855710)
56. M. Levitus, Q. Waisfisz, B. C. Godthelp, Y. de Vries, S. Hussain, W. W. Wiegant, E. Elghalbzouri-Maghrani, J. Steltenpool, M. A. Rooimans, G. Pals, F. Arwert, C. G. Mathew, M. Z. Zdzienicka, K. Hiom, J. P. De Winter and H. Joenje: The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet, 37(9), 934-5 (2005). (Pubitemid 43086148)
57. O. Levran, C. Attwooll, R. T. Henry, K. L. Milton, K. Neveling, P. Rio, S. D. Batish, R. Kalb, E. Velleuer, S. Barral, J. Ott, J. Petrini, D. Schindler, H. Hanenberg and A. D. Auerbach: The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet, 37(9), 931-3 (2005). (Pubitemid 43086147)
58. R. Litman, M. Peng, Z. Jin, F. Zhang, J. Zhang, S. Powell, P. R. Andreassen and S. B. Cantor: BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell, 8(3), 255-65 (2005). (Pubitemid 41317595)
59. A. R. Meetei, Z. Yan and W. Wang: FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle, 3(2), 179-81 (2004). (Pubitemid 40268694)
60. A. R. Meetei, A. L. Medhurst, C. Ling, Y. Xue, T. R. Singh, P. Bier, J. Steltenpool, S. Stone, I. Dokal, C. G. Mathew, M. Hoatlin, H. Joenje, J. P. de Winter and W. Wang: A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet, 37(9), 958-63 (2005). (Pubitemid 43086152)
61. G. Mosedale, W. Niedzwiedz, A. Alpi, F. Perrina, J. B. Pereira-Leal, M. Johnson, F. Langevin, P. Pace and K. J. Patel: The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat Struct Mol Biol, 12(9), 763-71 (2005). (Pubitemid 43086250)
62. S. Reid, D. Schindler, H. Hanenberg, K. Barker, S. Hanks, R. Kalb, K. Neveling, P. Kelly, S. Seal, M. Freund, M. Wurm, S. D. Batish, F. P. Lach, S. Yetgin, H. Neitzel, H. Ariffin, M. Tischkowitz, C. G. Mathew, A. D. Auerbach and N. Rahman: Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet, 39(2), 162-4 (2007). (Pubitemid 46184345)
63. B. Xia, J. C. Dorsman, N. Ameziane, Y. de Vries, M. A. Rooimans, Q. Sheng, G. Pals, A. Errami, E. Gluckman, J. Llera, W. Wang, D. M. Livingston, H. Joenje and J. P. de Winter: Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet, 39(2), 159-61 (2007). (Pubitemid 46184344)
64. I. Garcia-Higuera, T. Taniguchi, S. Ganesan, M. S. Meyn, C. Timmers, J. Hejna, M. Grompe and A. D. D'Andrea: Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell, 7(2), 249-62 (2001). (Pubitemid 32206493)
65. A. R. Meetei, J. P. de Winter, A. L. Medhurst, M. Wallisch, Q. Waisfisz, H. J. van de Vrugt, A. B. Oostra, Z. Yan, C. Ling, C. E. Bishop, M. E. Hoatlin, H. Joenje and W. Wang: A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet, 35(2), 165-70 (2003). (Pubitemid 37187635)
66. T. Taniguchi, I. Garcia-Higuera, P. R. Andreassen, R. C. Gregory, M. Grompe and A. D. D'Andrea: S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, 100(7), 2414-20 (2002).
67. P. R. Andreassen, A. D. D'Andrea and T. Taniguchi: ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev, 18(16), 1958-63 (2004). (Pubitemid 39071576)
68. J. Dunn, M. Potter, A. Rees and T. M. Runger: Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light. Cancer Res, 66(23), 11140-7 (2006). (Pubitemid 46009940)
69. N. G. Howlett, T. Taniguchi, S. G. Durkin, A. D. D'Andrea and T. W. Glover: The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet, 14(5), 693-701 (2005). (Pubitemid 40309594)
70. J. P. de Winter and H. Joenje: The genetic and molecular basis of Fanconi anemia. Mutat Res, 668(1-2), 11-9 (2009).
71. A. F. Alpi and K. J. Patel: Monoubiquitylation in the Fanconi anemia DNA damage response pathway. DNA Repair (Amst), 8(4), 430-5 (2009).
72. A. M. Ali, T. R. Singh and A. R. Meetei: FANCMFAAP24 and FANCJ: FA proteins that metabolize DNA. Mutat Res, 668(1-2), 20-6 (2009).
73. P. R. Andreassen and K. Ren: Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy. Curr Cancer Drug Targets, 9(1), 101-17 (2009).
74. D. T. Bergstralh and J. Sekelsky: Interstrand crosslink repair: can XPF-ERCC1 be let off the hook? Trends Genet, 24(2), 70-6 (2008).
75. A. Ciccia, N. McDonald and S. C. West: Structural and functional relationships of the XPF/MUS81 family of proteins. Annu Rev Biochem, 77, 259-87 (2008).
76. K. D. Mirchandani and A. D. D'Andrea: The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair. Exp Cell Res, 312(14), 2647-53 (2006). (Pubitemid 44162921)
77. Q. Wu and K. M. Vasquez: Human MLH1 protein participates in genomic damage checkpoint signaling in response to DNA interstrand crosslinks, while MSH2 functions in DNA repair. PLoS Genet, 4(9), e1000189 (2008).
78. N. Zhang, X. Liu, L. Li and R. Legerski: Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1- XPF, REV3, and the Fanconi anemia pathway. DNA Repair (Amst), 6(11), 1670-8 (2007). (Pubitemid 47600111)
79. N. Zhang, X. Lu, X. Zhang, C. A. Peterson and R. J. Legerski: hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol Cell Biol, 22(7), 2388-97 (2002). (Pubitemid 34224641)
80. J. Zhao, A. Jain, R. R. Iyer, P. L. Modrich and K. M. Vasquez: Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks. Nucleic Acids Res, 37(13), 4420-9 (2009).
81. I. G. Minko, M. B. Harbut, I. D. Kozekov, A. Kozekova, P. M. Jakobs, S. B. Olson, R. E. Moses, T. M. Harris, C. J. Rizzo and R. S. Lloyd: Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links. J Biol Chem, 283(25), 17075-82 (2008).
82. K. D. Mirchandani, R. M. McCaffrey and A. D. D'Andrea: The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair (Amst), 7(6), 902-11 (2008).
83. W. Niedzwiedz, G. Mosedale, M. Johnson, C. Y. Ong, P. Pace and K. J. Patel: The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol Cell, 15(4), 607-20 (2004). (Pubitemid 39141787)
84. A. R. Meetei, S. Sechi, M. Wallisch, D. Yang, M. K. Young, H. Joenje, M. E. Hoatlin and W. Wang: A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol, 23(10), 3417-26 (2003). (Pubitemid 36539175)
85. R. Guo, D. Xu and W. Wang: Identification and analysis of new proteins involved in the DNA damage response network of Fanconi anemia and Bloom syndrome. Methods, 48(1), 72-9 (2009).
86. A. Ciccia, C. Ling, R. Coulthard, Z. Yan, Y. Xue, A. R. Meetei, H. Laghmani el, H. Joenje, N. McDonald, J. P. de Winter, W. Wang and S. C. West: Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell, 25(3), 331-43 (2007). (Pubitemid 46206138)
87. C. Ling, M. Ishiai, A. M. Ali, A. L. Medhurst, K. Neveling, R. Kalb, Z. Yan, Y. Xue, A. B. Oostra, A. D. Auerbach, M. E. Hoatlin, D. Schindler, H. Joenje, J. P. de Winter, M. Takata, A. R. Meetei and W. Wang: FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. Embo J, 26(8), 2104-2114 (2007). (Pubitemid 46625801)
88. I. Garcia-Higuera, Y. Kuang, J. Denham and A. D. D'Andrea: The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood, 96(9), 3224-30 (2000).
89. A. L. Medhurst, H. Laghmani el, J. Steltenpool, M. Ferrer, C. Fontaine, J. de Groot, M. A. Rooimans, R. J. Scheper, A. R. Meetei, W. Wang, H. Joenje and J. P. de Winter: Evidence for subcomplexes in the Fanconi anemia pathway. Blood, 108(6), 2072-80 (2006). (Pubitemid 44395023)
90. S. M. Gordon and M. Buchwald: Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood, 102(1), 136-41 (2003). (Pubitemid 36759646)
91. T. Taniguchi and A. D. D'Andrea: The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood, 100(7), 2457-62 (2002).
92. C. S. Tremblay, F. F. Huang, O. Habi, C. C. Huard, C. Godin, G. Levesque and M. Carreau: HES1 is a novel interactor of the Fanconi anemia core complex. Blood, 112(5), 2062-70 (2008).
93. C. S. Tremblay, C. C. Huard, F. F. Huang, O. Habi, V. Bourdages, G. Levesque and M. Carreau: The fanconi anemia core complex acts as a transcriptional co-regulator in hairy enhancer of split 1 signaling. J Biol Chem, 284(20), 13384-95 (2009).
94. J. W. Harper and S. J. Elledge: The DNA damage response: ten years after. Mol Cell, 28(5), 739-45 (2007). (Pubitemid 350217064)
95. A. Sancar, L. A. Lindsey-Boltz, K. Unsal-Kacmaz and S. Linn: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem, 73, 39-85 (2004). (Pubitemid 39050363)
96. T. S. Byun, M. Pacek, M. C. Yee, J. C. Walter and K. A. Cimprich: Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev, 19(9), 1040-52 (2005). (Pubitemid 40632450)
97. P. Pichierri and F. Rosselli: The DNA crosslinkinduced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. Embo J, 23(5), 1178-87 (2004). (Pubitemid 38436881)
98. P. Pichierri, D. Averbeck and F. Rosselli: DNA crosslink- dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum Mol Genet, 11(21), 2531-46 (2002). (Pubitemid 35174684)
99. P. Pichierri and F. Rosselli: Fanconi anemia proteins and the s phase checkpoint. Cell Cycle, 3(6), 698-700 (2004). (Pubitemid 40187891)
100. S. J. Collis, A. Ciccia, A. J. Deans, Z. Horejsi, J. S. Martin, S. L. Maslen, J. M. Skehel, S. J. Elledge, S. C. West and S. J. Boulton: FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol Cell, 32(3), 313-24 (2008).
101. N. B. Collins, J. B. Wilson, T. Bush, A. Thomashevski, K. J. Roberts, N. J. Jones and G. M. Kupfer: ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. Blood, 113(10), 2181-90 (2009).
102. X. Wang, R. D. Kennedy, K. Ray, P. Stuckert, T. Ellenberger and A. D. D'Andrea: Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol Cell Biol, 27(8), 3098-108 (2007). (Pubitemid 46581321)
103. J. M. Kim, Y. Kee, A. Gurtan and A. D. D'Andrea: Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood, 111(10), 5215-22 (2008).
104. A. Sobeck, S. Stone, I. Landais, B. de Graaf and M. E. Hoatlin: The fanconi anemia protein FANCM is controlled by FANCD2 and the ATR/ATM pathways. J Biol Chem, 284(38), 25560-8 (2009).
105. Y. Kee, J. M. Kim and A. D. D'Andrea: Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. Genes Dev, 23(5), 555-60 (2009).
106. M. B. Yaffe and A. E. Elia: Phosphoserine/threoninebinding domains. Curr Opin Cell Biol, 13(2), 131-8 (2001).
107. A. M. Gurtan, P. Stuckert and A. D. D'Andrea: The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly. J Biol Chem, 281(16), 10896-905 (2006). (Pubitemid 43855513)
108. A. Shimamura, R. Montes de Oca, J. L. Svenson, N. Haining, L. A. Moreau, D. G. Nathan and A. D. D'Andrea: A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood, 100(13), 4649-54 (2002). (Pubitemid 35429710)
109. J. Soulier, T. Leblanc, J. Larghero, H. Dastot, A. Shimamura, P. Guardiola, H. Esperou, C. Ferry, C. Jubert, J. P. Feugeas, A. Henri, A. Toubert, G. Socie, A. Baruchel, F. Sigaux, A. D. D'Andrea and E. Gluckman: Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood, 105(3), 1329-36 (2005). (Pubitemid 40170910)
110. Y. J. Machida, Y. Machida, Y. Chen, A. M. Gurtan, G. M. Kupfer, A. D. D'Andrea and A. Dutta: UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell, 23(4), 589-96 (2006). (Pubitemid 44205488)
111. A. Alpi, F. Langevin, G. Mosedale, Y. J. Machida, A. Dutta and K. J. Patel: UBE2T, the FA core complex and FANCD2 are recruited independently to chromatin: A basis for the regulation of FANCD2 monoubiquitination. Mol Cell Biol, 27(24), 8421-30 (2007).
112. I. V. Rosado, W. Niedzwiedz, A. F. Alpi and K. J. Patel: The Walker B motif in avian FANCM is required to limit sister chromatid exchanges but is dispensable for DNA crosslink repair. Nucleic Acids Res, 37(13), 4360-70 (2009).
113. R. Montes de Oca, P. R. Andreassen, S. P. Margossian, R. C. Gregory, T. Taniguchi, X. Wang, S. Houghtaling, M. Grompe and A. D. D'Andrea: Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood, 105(3), 1003-9 (2005). (Pubitemid 40170868)
114. T. R. Singh, S. T. Bakker, S. Agarwal, M. Jansen, E. Grassman, B. C. Godthelp, A. M. Ali, C. H. Du, M. A. Rooimans, Q. Fan, K. Wahengbam, J. Steltenpool, P. R. Andreassen, D. A. Williams, H. Joenje, J. P. de Winter and A. R. Meetei: Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M. Blood, 114(1), 174-80 (2009).
115. S. T. Bakker, H. J. van de Vrugt, M. A. Rooimans, A. B. Oostra, J. Steltenpool, E. Delzenne-Goette, A. van der Wal, M. van der Valk, H. Joenje, H. Te Riele and J. P. de Winter: Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M. Hum Mol Genet, 18(18), 3484-95 (2009).
116. N. C. Cheng, H. J. van de Vrugt, M. A. van der Valk, A. B. Oostra, P. Krimpenfort, Y. de Vries, H. Joenje, A. Berns and F. Arwert: Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet, 9(12), 1805-11 (2000). (Pubitemid 30608614)
117. J. C. Wong, N. Alon, C. McKerlie, J. R. Huang, M. S. Meyn and M. Buchwald: Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum Mol Genet, 12(16), 2063-76 (2003). (Pubitemid 37038815)
118. M. A. Whitney, G. Royle, M. J. Low, M. A. Kelly, M. K. Axthelm, C. Reifsteck, S. Olson, R. E. Braun, M. C. Heinrich, R. K. Rathbun, G. C. Bagby and M. Grompe: Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood, 88(1), 49-58 (1996). (Pubitemid 26230670)
119. M. Chen, D. J. Tomkins, W. Auerbach, C. McKerlie, H. Youssoufian, L. Liu, O. Gan, M. Carreau, A. Auerbach, T. Groves, C. J. Guidos, M. H. Freedman, J. Cross, D. H. Percy, J. E. Dick, A. L. Joyner and M. Buchwald: Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet, 12(4), 448-51 (1996). (Pubitemid 26105940)
120. M. Koomen, N. C. Cheng, H. J. van de Vrugt, B. C. Godthelp, M. A. van der Valk, A. B. Oostra, M. Z. Zdzienicka, H. Joenje and F. Arwert: Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Hum Mol Genet, 11(3), 273-81 (2002). (Pubitemid 34173356)
121. Y. Yang, Y. Kuang, R. Montes De Oca, T. Hays, L. Moreau, N. Lu, B. Seed and A. D. D'Andrea: Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood, 98(12), 3435-40 (2001).
122. K. R. Kumaresan and M. W. Lambert: Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis, 21(4), 741-51 (2000). (Pubitemid 30214032)
123. K. R. Kumaresan, D. M. Sridharan, L. W. McMahon and M. W. Lambert: Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells. Biochemistry, 46(50), 14359-68 (2007). (Pubitemid 350284561)
124. D. Papadopoulo, B. Porfirio and E. Moustacchi: Mutagenic response of Fanconi's anemia cells from a defined complementation group after treatment with photoactivated bifunctional psoralens. Cancer Res, 50(11), 3289-94 (1990). (Pubitemid 20190133)
125. Y. G. Yang, Z. Herceg, K. Nakanishi, I. Demuth, C. Piccoli, J. Michelon, G. Hildebrand, M. Jasin, M. Digweed and Z. Q. Wang: The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis, 26(10), 1731-40 (2005). (Pubitemid 41487988)
126. H. Kitao, K. Yamamoto, N. Matsushita, M. Ohzeki, M. Ishiai and M. Takata: Functional interplay between BRCA2/FancD1 and FancC in DNA repair. J Biol Chem, 281(30), 21312-20 (2006). (Pubitemid 44115470)
127. S. Hussain, J. B. Wilson, E. Blom, L. H. Thompson, P. Sung, S. M. Gordon, G. M. Kupfer, H. Joenje, C. G. Mathew and N. J. Jones: Tetratricopeptide-motif- mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair (Amst), 5(5), 629-40 (2006).
128. S. Hussain, E. Witt, P. A. Huber, A. L. Medhurst, A. Ashworth and C. G. Mathew: Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet, 12(19), 2503-10 (2003). (Pubitemid 37220414)
129. M. Seliskar and D. Rozman: Mammalian cytochromes P450-importance of tissue specificity. Biochim Biophys Acta, 1770(3), 458-66 (2007). (Pubitemid 46136750)
130. S. S. Mukhopadhyay, K. S. Leung, M. J. Hicks, P. J. Hastings, H. Youssoufian and S. E. Plon: Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol, 175(2), 225-35 (2006). (Pubitemid 44631417)
131. R. C. Cumming, J. Lightfoot, K. Beard, H. Youssoufian, P. J. O'Brien and M. Buchwald: Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med, 7(7), 814-20 (2001). (Pubitemid 32691636)
132. A. Zunino, P. Degan, T. Vigo and A. Abbondandolo: Hydrogen peroxide: effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi's anemia cell lines. Mutagenesis, 16(3), 283-8 (2001). (Pubitemid 32447763)
133. T. Taniguchi, I. Garcia-Higuera, B. Xu, P. R. Andreassen, R. C. Gregory, S. T. Kim, W. S. Lane, M. B. Kastan and A. D. D'Andrea: Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell, 109(4), 459-72 (2002). (Pubitemid 34564473)
134. M. Ishiai, H. Kitao, A. Smogorzewska, J. Tomida, A. Kinomura, E. Uchida, A. Saberi, E. Kinoshita, E. Kinoshita-Kikuta, T. Koike, S. Tashiro, S. J. Elledge and M. Takata: FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat Struct Mol Biol, 15(11), 1138-46 (2008).
135. G. P. Ho, S. Margossian, T. Taniguchi and A. D. D'Andrea: Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol Cell Biol, 26(18), 7005-15 (2006). (Pubitemid 44387648)
136. M. Bogliolo, A. Lyakhovich, E. Callen, M. Castella, E. Cappelli, M. J. Ramirez, A. Creus, R. Marcos, R. Kalb, K. Neveling, D. Schindler and J. Surralles: Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. Embo J, 26(5), 1340-51 (2007). (Pubitemid 46398698)
137. S. B. Cantor, D. W. Bell, S. Ganesan, E. M. Kass, R. Drapkin, S. Grossman, D. C. Wahrer, D. C. Sgroi, W. S. Lane, D. A. Haber and D. M. Livingston: BACH1, a novel helicaselike protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell, 105(1), 149-60 (2001). (Pubitemid 32323924)
138. A. Folias, M. Matkovic, D. Bruun, S. Reid, J. Hejna, M. Grompe, A. D'Andrea and R. Moses: BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum Mol Genet, 11(21), 2591-7 (2002). (Pubitemid 35174689)
139. S. Hussain, J. B. Wilson, A. L. Medhurst, J. Hejna, E. Witt, S. Ananth, A. Davies, J. Y. Masson, R. Moses, S. C. West, J. P. de Winter, A. Ashworth, N. J. Jones and C. G. Mathew: Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum Mol Genet, 13(12), 1241-8 (2004). (Pubitemid 38877877)
140. X. Wang, P. R. Andreassen and A. D. D'Andrea: Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol, 24(13), 5850-62 (2004). (Pubitemid 38787970)
141. B. Xia, Q. Sheng, K. Nakanishi, A. Ohashi, J. Wu, N. Christ, X. Liu, M. Jasin, F. J. Couch and D. M. Livingston: Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell, 22(6), 719-29 (2006).
142. A. F. Alpi, P. E. Pace, M. M. Babu and K. J. Patel: Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell, 32(6), 767-77 (2008).
143. S. Longerich, J. San Filippo, D. Liu and P. Sung: Fanci binds branched DNA and is mono-ubiquitinated by UBE2T-FANCL. J Biol Chem, 284(35), 23182-6 (2009).
144. N. Matsushita, H. Kitao, M. Ishiai, N. Nagashima, S. Hirano, K. Okawa, T. Ohta, D. S. Yu, P. J. McHugh, I. D. Hickson, A. R. Venkitaraman, H. Kurumizaka and M. Takata: A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol Cell, 19(6), 841-7 (2005). (Pubitemid 41316677)
145. M. A. Cohn and A. D. D'Andrea: Chromatin recruitment of DNA repair proteins: lessons from the fanconi anemia and double-strand break repair pathways. Mol Cell, 32(3), 306-12 (2008).
146. M. A. Cohn, Y. Kee, W. Haas, S. P. Gygi and A. D. D'Andrea: UAF1 is a subunit of multiple deubiquitinating enzyme complexes. J Biol Chem, 284(8), 5343-51 (2009).
147. M. A. Cohn, P. Kowal, K. Yang, W. Haas, T. T. Huang, S. P. Gygi and A. D. D'Andrea: A UAF1- containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol Cell, 28(5), 786-97 (2007). (Pubitemid 350217060)
148. S. M. Nijman, T. T. Huang, A. M. Dirac, T. R. Brummelkamp, R. M. Kerkhoven, A. D. D'Andrea and R. Bernards: The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell, 17(3), 331-9 (2005). (Pubitemid 40193305)
149. V. H. Oestergaard, F. Langevin, H. J. Kuiken, P. Pace, W. Niedzwiedz, L. J. Simpson, M. Ohzeki, M. Takata, J. E. Sale and K. J. Patel: Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol Cell, 28(5), 798- 809 (2007). (Pubitemid 350217050)
150. W. H. Park, S. Margossian, A. A. Horwitz, A. M. Simons, A. D. D'Andrea and J. D. Parvin: Direct DNA binding activity of the Fanconi anemia D2 protein. J Biol Chem, 280(25), 23593-8 (2005). (Pubitemid 40884838)
151. C. Roques, Y. Coulombe, M. Delannoy, J. Vignard, S. Grossi, I. Brodeur, A. Rodrigue, J. Gautier, A. Z. Stasiak, A. Stasiak, A. Constantinou and J. Y. Masson: MRE11- RAD50-NBS1 is a critical regulator of FANCD2 stability and function during DNA double-strand break repair. Embo J, 28(16), 2400-13 (2009).
152. S. M. Gordon, N. Alon and M. Buchwald: FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway. J Biol Chem, 280(43), 36118-25 (2005). (Pubitemid 41633883)
153. P. Pace, M. Johnson, W. M. Tan, G. Mosedale, C. Sng, M. Hoatlin, J. de Winter, H. Joenje, F. Gergely and K. J. Patel: FANCE: the link between Fanconi anaemia complex assembly and activity. Embo J, 21(13), 3414-23 (2002). (Pubitemid 34760573)
154. P. Knipscheer, M. Raschle, A. Smogorzewska, M. Enoiu, T. V. Ho, O. D. Scharer, S. J. Elledge and J. C. Walter: The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair. Science (2009) doi:10.1126/science.1182372.
155. J. Mi and G. M. Kupfer: The Fanconi anemia core complex associates with chromatin during S phase. Blood, 105(2), 759-66 (2005). (Pubitemid 40070763)
156. P. J. McKinnon and K. W. Caldecott: DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet, 8, 37-55 (2007).
157. K. Hanada, M. Budzowska, M. Modesti, A. Maas, C. Wyman, J. Essers and R. Kanaar: The structurespecific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. Embo J, 25(20), 4921-32 (2006). (Pubitemid 44607036)
158. J. B. Wilson, K. Yamamoto, A. S. Marriott, S. Hussain, P. Sung, M. E. Hoatlin, C. G. Mathew, M. Takata, L. H. Thompson, G. M. Kupfer and N. J. Jones: FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene, 27(26), 3641-52 (2008). (Pubitemid 351912967)
159. N. Bhagwat, A. L. Olsen, A. T. Wang, K. Hanada, P. Stuckert, R. Kanaar, A. D'Andrea, L. J. Niedernhofer and P. J. McHugh: XPF-ERCC1 participates in the Fanconi anemia pathway of crosslink repair. Mol Cell Biol, 29(24), 6427-37 (2009).
160. K. M. McCabe, A. Hemphill, Y. Akkari, P. M. Jakobs, D. Pauw, S. B. Olson, R. E. Moses and M. Grompe: ERCC1 is required for FANCD2 focus formation. Mol Genet Metab, 95(1-2), 66-73 (2008).
161. K. Parmar, A. D'Andrea and L. J. Niedernhofer: Mouse models of Fanconi anemia. Mutat Res, 668(1-2), 133-40 (2009).
162. H. Yang, P. D. Jeffrey, J. Miller, E. Kinnucan, Y. Sun, N. H. Thoma, N. Zheng, P. L. Chen, W. H. Lee and N. P. Pavletich: BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science, 297(5588), 1837-48 (2002). (Pubitemid 35024337)
163. J. San Filippo, P. Chi, M. G. Sehorn, J. Etchin, L. Krejci and P. Sung: Recombination mediator and Rad51 targeting activities of a human BRCA2 polypeptide. J Biol Chem, 281(17), 11649-57 (2006). (Pubitemid 43855422)
164. S. Navarro, N. W. Meza, O. Quintana-Bustamante, J. A. Casado, A. Jacome, K. McAllister, S. Puerto, J. Surralles, J. C. Segovia and J. A. Bueren: Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther, 14(4), 525-35 (2006). (Pubitemid 44296097)
165. P. Rio, J. C. Segovia, H. Hanenberg, J. A. Casado, J. Martinez, K. Gottsche, N. C. Cheng, H. J. Van de Vrugt, F. Arwert, H. Joenje and J. A. Bueren: In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice. Blood, 100(6), 2032-9 (2002). (Pubitemid 35001234)
166. B. C. Godthelp, F. Artwert, H. Joenje and M. Z. Zdzienicka: Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene, 21(32), 5002-5 (2002).
167. B. C. Godthelp, W. W. Wiegant, Q. Waisfisz, A. L. Medhurst, F. Arwert, H. Joenje and M. Z. Zdzienicka: Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat Res, 594(1-2), 39-48 (2006). (Pubitemid 43170985)
168. M. Tarsounas, D. Davies and S. C. West: BRCA2- dependent and independent formation of RAD51 nuclear foci. Oncogene, 22(8), 1115-23 (2003). (Pubitemid 36363377)
169. B. S. Atanassov, J. C. Barrett and B. J. Davis: Homozygous germ line mutation in exon 27 of murine Brca2 disrupts the Fancd2-Brca2 pathway in the homologous recombination-mediated DNA interstrand cross-links' repair but does not affect meiosis. Genes Chromosomes Cancer, 44(4), 429-37 (2005). (Pubitemid 41476794)
170. N. Rahman, S. Seal, D. Thompson, P. Kelly, A. Renwick, A. Elliott, S. Reid, K. Spanova, R. Barfoot, T. Chagtai, H. Jayatilake, L. McGuffog, S. Hanks, D. G. Evans, D. Eccles, D. F. Easton and M. R. Stratton: PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet, 39(2), 165-7 (2007). (Pubitemid 46184346)
171. S. M. Sy, M. S. Huen and J. Chen: PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci U S A, 106(17), 7155-60 (2009).
172. S. M. Sy, M. S. Huen, Y. Zhu and J. Chen: PALB2 regulates recombinational repair through chromatin association and oligomerization. J Biol Chem, 284(27), 18302-10 (2009).
173. S. Cantor, R. Drapkin, F. Zhang, Y. Lin, J. Han, S. Pamidi and D. M. Livingston: The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc Natl Acad Sci U S A, 101(8), 2357-62 (2004). (Pubitemid 38269316)
174. R. Gupta, S. Sharma, J. A. Sommers, Z. Jin, S. B. Cantor and R. M. Brosh Jr.: Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J Biol Chem, 280(27), 25450-60 (2005). (Pubitemid 40962249)
175. R. A. Greenberg, B. Sobhian, S. Pathania, S. B. Cantor, Y. Nakatani and D. M. Livingston: Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1- containing complexes. Genes Dev, 20(1), 34-46 (2006). (Pubitemid 43042666)
176. T. T. Paull, D. Cortez, B. Bowers, S. J. Elledge and M. Gellert: Direct DNA binding by Brca1. Proc Natl Acad Sci U S A, 98(11), 6086-91 (2001). (Pubitemid 32488197)
177. X. Shen, H. Do, Y. Li, W. H. Chung, M. Tomasz, J. P. de Winter, B. Xia, S. J. Elledge, W. Wang and L. Li: Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. Mol Cell, 35(5), 716-23 (2009).
178. M. Escarceller, M. Buchwald, B. K. Singleton, P. A. Jeggo, S. P. Jackson, E. Moustacchi and D. Papadopoulo: Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J Mol Biol, 279(2), 375-85 (1998). (Pubitemid 28263977)
179. L. J. Niedernhofer, G. A. Garinis, A. Raams, A. S. Lalai, A. R. Robinson, E. Appeldoorn, H. Odijk, R. Oostendorp, A. Ahmad, W. van Leeuwen, A. F. Theil, W. Vermeulen, G. T. van der Horst, P. Meinecke, W. J. Kleijer, J. Vijg, N. G. Jaspers and J. H. Hoeijmakers: A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature, 444(7122), 1038-43 (2006). (Pubitemid 46018517)
180. C. A. Hoy, L. H. Thompson, C. L. Mooney and E. P. Salazar: Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res, 45(4), 1737-43 (1985). (Pubitemid 15079132)
181. L. H. Thompson, J. S. Rubin, J. E. Cleaver, G. F. Whitmore and K. Brookman: A screening method for isolating DNA repair-deficient mutants of CHO cells. Somatic Cell Genet, 6(3), 391-405 (1980). (Pubitemid 10113596)
182. P. H. Clingen, I. U. De Silva, P. J. McHugh, F. J. Ghadessy, M. J. Tilby, D. E. Thurston and J. A. Hartley: The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2, 1-c][1, 4]benzodiazepine dimer SJG-136. Nucleic Acids Res, 33(10), 3283-91 (2005). (Pubitemid 41194472)
183. B. S. Andersson, T. Sadeghi, M. J. Siciliano, R. Legerski and D. Murray: Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharmacol, 38(5), 406-16 (1996). (Pubitemid 26281077)
184. L. A. Fisher, M. Bessho and T. Bessho: Processing of a psoralen DNA interstrand cross-link by XPF-ERCC1 complex in vitro. J Biol Chem, 283(3), 1275-81 (2008).
185. I. Kuraoka, W. R. Kobertz, R. R. Ariza, M. Biggerstaff, J. M. Essigmann and R. D. Wood: Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J Biol Chem, 275(34), 26632-6 (2000).
186. J. M. Prasher, A. S. Lalai, C. Heijmans-Antonissen, R. E. Ploemacher, J. H. Hoeijmakers, I. P. Touw and L. J. Niedernhofer: Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1-/- mice. Embo J, 24(4), 861-71 (2005). (Pubitemid 40396114)
187. S. A. Bastin-Shanower, W. M. Fricke, J. R. Mullen and S. J. Brill: The mechanism of Mus81-Mms4 cleavage site selection distinguishes it from the homologous endonuclease Rad1-Rad10. Mol Cell Biol, 23(10), 3487-96 (2003). (Pubitemid 36539181)
188. A. Ciccia, A. Constantinou and S. C. West: Identification and characterization of the human mus81- eme1 endonuclease. J Biol Chem, 278(27), 25172-8 (2003). (Pubitemid 37548682)
189. P. H. Gaillard, E. Noguchi, P. Shanahan and P. Russell: The endogenous Mus81-Eme1 complex resolves Holliday junctions by a nick and counternick mechanism. Mol Cell, 12(3), 747-59 (2003). (Pubitemid 37222494)
190. F. Osman, J. Dixon, C. L. Doe and M. C. Whitby: Generating crossovers by resolution of nicked Holliday junctions: a role for Mus81-Eme1 in meiosis. Mol Cell, 12(3), 761-74 (2003). (Pubitemid 37222495)
191. L. J. Gaskell, F. Osman, R. J. Gilbert and M. C. Whitby: Mus81 cleavage of Holliday junctions: a failsafe for processing meiotic recombination intermediates? Embo J, 26(7), 1891-901 (2007). (Pubitemid 46624056)
192. S. Fekairi, S. Scaglione, C. Chahwan, E. R. Taylor, A. Tissier, S. Coulon, M. Q. Dong, C. Ruse, J. R. Yates 3rd, P. Russell, R. P. Fuchs, C. H. McGowan and P. H. Gaillard: Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell, 138(1), 78-89 (2009).
193. I. M. Munoz, K. Hain, A. C. Declais, M. Gardiner, G. W. Toh, L. Sanchez-Pulido, J. M. Heuckmann, R. Toth, T. Macartney, B. Eppink, R. Kanaar, C. P. Ponting, D. M. Lilley and J. Rouse: Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol Cell, 35(1), 116-27 (2009).
194. J. M. Svendsen, A. Smogorzewska, M. E. Sowa, B. C. O'Connell, S. P. Gygi, S. J. Elledge and J. W. Harper: Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell, 138(1), 63- 77 (2009).
195. S. L. Andersen, D. T. Bergstralh, K. P. Kohl, J. R. LaRocque, C. B. Moore and J. Sekelsky: Drosophila MUS312 and the vertebrate ortholog BTBD12 interact with DNA structure-specific endonucleases in DNA repair and recombination. Mol Cell, 35(1), 128-35 (2009).
196. E. C. Friedberg, R. Wagner and M. Radman: Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science, 296(5573), 1627-30 (2002). (Pubitemid 34579143)
197. M. F. Goodman: Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu Rev Biochem, 71, 17- 50 (2002). (Pubitemid 34800213)
198. S. Prakash, R. E. Johnson and L. Prakash: Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem, 74, 317-53 (2005). (Pubitemid 40995510)
199. K. Nojima, H. Hochegger, A. Saberi, T. Fukushima, K. Kikuchi, M. Yoshimura, B. J. Orelli, D. K. Bishop, S. Hirano, M. Ohzeki, M. Ishiai, K. Yamamoto, M. Takata, H. Arakawa, J. M. Buerstedde, M. Yamazoe, T. Kawamoto, K. Araki, J. A. Takahashi, N. Hashimoto, S. Takeda and E. Sonoda: Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res, 65(24), 11704-11 (2005). (Pubitemid 41821731)
200. X. Shen, S. Jun, L. E. O'Neal, E. Sonoda, M. Bemark, J. E. Sale and L. Li: REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand crosslinks mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA). J Biol Chem, 281(20), 13869-72 (2006). (Pubitemid 43848310)
201. S. Sarkar, A. A. Davies, H. D. Ulrich and P. J. McHugh: DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase zeta. Embo J, 25(6), 1285-94 (2006).
202. L. Zander and M. Bemark: Immortalized mouse cell lines that lack a functional Rev3 gene are hypersensitive to UV irradiation and cisplatin treatment. DNA Repair (Amst), 3(7), 743-52 (2004). (Pubitemid 38716103)
203. T. Okada, E. Sonoda, M. Yoshimura, Y. Kawano, H. Saya, M. Kohzaki and S. Takeda: Multiple roles of vertebrate REV genes in DNA repair and recombination. Mol Cell Biol, 25(14), 6103-11 (2005). (Pubitemid 40946561)
204. E. Sonoda, T. Okada, G. Y. Zhao, S. Tateishi, K. Araki, M. Yamaizumi, T. Yagi, N. S. Verkaik, D. C. van Gent, M. Takata and S. Takeda: Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. Embo J, 22(12), 3188-97 (2003). (Pubitemid 36758638)
205. S. Mogi, C. E. Butcher and D. H. Oh: DNA polymerase eta reduces the gamma-H2AX response to psoralen interstrand crosslinks in human cells. Exp Cell Res, 314(4), 887-95 (2008).
206. L. J. Barber, T. A. Ward, J. A. Hartley and P. J. McHugh: DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. Mol Cell Biol, 25(6), 2297-309 (2005). (Pubitemid 40354626)
207. M. Peng, R. Litman, J. Xie, S. Sharma, R. M. Brosh Jr., and S. B. Cantor: The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. Embo J, 26(13), 3238-49 (2007). (Pubitemid 47057494)
208. Q. Wu, L. A. Christensen, R. J. Legerski and K. M. Vasquez: Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. EMBO Rep, 6(6), 551-7 (2005).
209. L. Lan, T. Hayashi, R. M. Rabeya, S. Nakajima, S. Kanno, M. Takao, T. Matsunaga, M. Yoshino, M. Ichikawa, H. Riele, S. Tsuchiya, K. Tanaka and A. Yasui: Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cisdiamminedichloroplatinum(II) in mammalian cells. DNA Repair (Amst), 3(2), 135-43 (2004). (Pubitemid 38045244)
210. F. A. Kadyrov, L. Dzantiev, N. Constantin and P. Modrich: Endonucleolytic function of MutLalpha in human mismatch repair. Cell, 126(2), 297-308 (2006). (Pubitemid 44092957)
211. P. Modrich: Mechanisms in eukaryotic mismatch repair. J Biol Chem, 281(41), 30305-9 (2006). (Pubitemid 44582082)
212. N. A. Ellis, D. J. Lennon, M. Proytcheva, B. Alhadeff, E. E. Henderson and J. German: Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells. Am J Hum Genet, 57(5), 1019-27 (1995).
213. P. Pichierri, A. Franchitto and F. Rosselli: BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. Embo J, 23(15), 3154- 63 (2004). (Pubitemid 39093609)
214. V. Naim and F. Rosselli: The FANC pathway and BLM collaborate during mitosis to prevent micronucleation and chromosome abnormalities. Nat Cell Biol, 11(6), 761-8 (2009).
215. K. Nakanishi, T. Taniguchi, V. Ranganathan, H. V. New, L. A. Moreau, M. Stotsky, C. G. Mathew, M. B. Kastan, D. T. Weaver and A. D. D'Andrea: Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol, 4(12), 913-20 (2002). (Pubitemid 35469420)
216. M. N. Boddy, P. H. Gaillard, W. H. McDonald, P. Shanahan, J. R. Yates 3rd and P. Russell: Mus81-Eme1 are essential components of a Holliday junction resolvase. Cell, 107(4), 537-48 (2001). (Pubitemid 33152788)
217. W. M. Fricke, S. A. Bastin-Shanower and S. J. Brill: Substrate specificity of the Saccharomyces cerevisiae Mus81-Mms4 endonuclease. DNA Repair (Amst), 4(2), 243-51 (2005). (Pubitemid 39601412)
218. P. J. McHugh, V. J. Spanswick and J. A. Hartley: Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol, 2(8), 483-90 (2001). (Pubitemid 33586303)
219. X. Wang, C. A. Peterson, H. Zheng, R. S. Nairn, R. J. Legerski and L. Li: Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol Cell Biol, 21(3), 713-20 (2001). (Pubitemid 32104720)
220. H. E. Bryant, N. Schultz, H. D. Thomas, K. M. Parker, D. Flower, E. Lopez, S. Kyle, M. Meuth, N. J. Curtin and T. Helleday: Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature, 434(7035), 913-7 (2005). (Pubitemid 40559005)
221. H. Farmer, N. McCabe, C. J. Lord, A. N. Tutt, D. A. Johnson, T. B. Richardson, M. Santarosa, K. J. Dillon, I. Hickson, C. Knights, N. M. Martin, S. P. Jackson, G. C. Smith and A. Ashworth: Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 434(7035), 917-21 (2005). (Pubitemid 40559006)
222. C. J. Lord, S. McDonald, S. Swift, N. C. Turner and A. Ashworth: A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity. DNA Repair (Amst), 7(12), 2010-9 (2008).
223. R. D. Kennedy, C. C. Chen, P. Stuckert, E. M. Archila, M. A. De la Vega, L. A. Moreau, A. Shimamura and A. D. D'Andrea: Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J Clin Invest, 117(5), 1440-9 (2007). (Pubitemid 46718432)